Search

You searched for "MRI"

161 results found

Announcing a new specialist distributor of medical devices for prostate cancer

10 January 2022 | Contracts & Distributors, Research & Development
Healthcare Supply Solutions are a new distributor focussed on medical devices for the diagnosis and management of Prostate Cancer.

Managing sustainability

2 April 2024 |
Planetary health needs to be addressed at a societal level for any meaningful impact to occur. As the global director of sustainability for a law firm, Marion Palmer provides an overview of the responsibilities of corporate organisations for both a...

Indication to pelvic lymph nodes dissection for prostate cancer

1 November 2018 | | URO - Urologic Oncology
This paper explored the role of multiparametric MRI (mpMRI) in predicting the likelihood of lymph node invasion in patients with a risk of <5% according to the Briganti nomogram. Three hundred and ten patients who underwent a preoperative mpMRI and...

Radium-223 treatment outcomes after multiple lines of mCRPC therapy in clinical practice: implication of pre-treatment spinal epidural disease

1 September 2017 | | URO - Urologic Oncology
There are a number of treatments now available to patients with metastatic castrate-resistant prostate cancer (mCRPC). However, the optimal timing and order in which they are given is less clear. Radium-223 was FDA-approved for mCRPC patients with symptomatic bone metastases...

Torsion of spermatic cord in children

1 March 2014 | | URO - Paediatric Urology
This is an excellent review of ‘testicular’ torsion - which is said to occur in 1:4000 under 25-year-olds. Two age periods (adolescence and neonatal) are identified as having peak incidence. Acute torsion represents 27% of children with acute scrotum. The...

Read all about it Jul/Aug 2021

1 July 2021 | | URO - Paediatric Urology, URO - Urologic Oncology
Read all about it... It can be awkward when a patient asks you about a report in their favourite tabloid detailing an amazing research breakthrough or a ‘cutting-edge’ new treatment / test and you don’t know what they are talking...

Read all about it May/Jun 2021

5 May 2021 | | URO - Urologic Oncology, URO - Functional / Reconstructive Urology
Read all about it... It can be awkward when a patient asks you about a report in their favourite tabloid detailing an amazing research breakthrough or a ‘cutting-edge’ new treatment / test and you don’t know what they are talking...

Testicular tumour imaging

1 January 2018 | | URO - Urologic Oncology, URO - Uroradiology
Testicular tumours are the most common tumour in young males with a peak incidence seen between 25 and 34 years [1]. The overall incidence is slowly increasing, although the exact reasons for this are uncertain, and there is a greater...

Indeterminate renal lesions – a pragmatic imaging approach

1 November 2016 | | URO - Uroradiology
The incidence of renal cell carcinoma (RCC) in the UK has increased steadily over the last two decades, largely driven by the increasing use of abdominal imaging and the incidental detection of small renal lesions [1]. The majority of incidental...

Trials offering cytoreductive surgery for men with de novo synchronous metastatic prostate cancer

8 November 2021 | | URO - Basic Science Research, URO - Urologic Oncology
Life expectancy in men diagnosed with de novo synchronous metastatic hormone-sensitive prostate cancer (mHSPC) has risen to a median of 4.8 years with upfront systemic agents (such as docetaxel) in addition to standard androgen deprivation therapy (ADT) [1-3]. Within this...

Recent developments in bladder cancer – MIBC

5 September 2022 | | URO - Urologic Oncology
This article takes a look back over recent years at new innovations and developments relating to muscle-invasive bladder cancer (MIBC) specifically, and will also touch upon what the future may hold. This article is also written as a continuation of...

Testicular cancer: management of stage I seminoma

1 July 2014 | | URO - Urologic Oncology
Introduction Testicular cancer is the most frequently occurring solid tumour in men between the ages of 15 and 34 years [1]. About 60% of cases are seminomas and approximately 70-80% of them have, at presentation, clinical stage I disease. This...